全球銀屑病藥物市場規模研究與預測：按藥物類別、分子類型、給藥途徑和地區分析，2022-2029 年

牛皮癬是一種皮膚病，皮膚細胞的更新速度比正常情況快。

牛皮癬與免疫系統有關，最常見於膝蓋、肘部、軀乾和頭皮。銀屑病發病率上升、對各種可用治療方案的認識不斷提高以及主要市場參與者的戰略舉措是推動市場增長的關鍵因素。

根據國家銀屑病基金會的數據，截至 2020 年，美國約有 800 萬人患有銀屑病。全球約有1.25億人患有銀屑病，佔世界人口的2-3%以上。此外，世界衛生組織 (WHO) 估計全世界約有 1 億人患有牛皮癬。此外，新興國家醫療基礎設施的發展和製藥行業研發活動的增加有望在預測期內為市場提供良好的增長前景。然而，與牛皮癬治療相關的高昂治療費用和與藥物治療相關的健康風險將阻礙整個 2022-2029 年預測期內的市場增長。

全球銀屑病治療市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於主要市場參與者的存在以及該地區銀屑病患病率的增加，北美已成為市場份額的領先地區。另一方面，由於藥品價格上漲和皮膚病增加等因素，預計亞太地區在預測期內將出現顯著增長。

本報告中的主要市場進入者包括：

• Astellas Pharma Inc.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• F. Hofffmann-La Roche
• GlaxoSmithKline plc
• Merck and Co., Inc.
• Valeant Pharmaceuticals International, Inc.
• Biocon Limited
• Eli Lilly and Company
• G and W Laboratories Inc.

市場的最新發展。

• 2021 年 10 月，印度的 Sun Pharmaceuticals Ltd. 在加拿大推出了一種名為 ILUMYA 的藥物，用於治療成人中度至重度斑塊狀銀屑病。
• 2021 年 12 月，美國食品和藥物管理局批准擴大使用安進公司的藥物 Otezla 治療成人輕度至中度斑塊狀銀屑病。這一批准使 Otezla 成為第一個也是唯一一個可用於成人尋常型銀屑病的口服治療選擇。

全球銀屑病藥物市場研究範圍。

歷史數據：2019-2020-2021

估計基準年：2021

預測期間：2022-2029

報告涵蓋的收入預測、公司排名、競爭格局、增長因素、趨勢

靶點治療分類、分子類型、給藥途徑、區域

區域範圍北美、歐洲、亞太地區、拉丁美洲、世界其他地區

覆蓋率報告的自定義是免費的（最多 8 小時的分析師時間）。添加或更改國家、地區或細分範圍*。

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測他們在未來幾年的價值。該報告旨在捕捉被調查國家工業的定性和定量方面。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。市場的詳細細分和子細分如下所述。

按藥物類別

腫瘤壞死因子抑製劑

PDE4抑製劑

白細胞介素阻滯劑

雜項

按分子類型

生物製品

低分子化合物

按給藥途徑

口語

親子

局部給藥

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地區

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 銀屑病藥物市場（按地區）：2019-2029
  • 按藥物類別劃分的銀屑病藥物市場：2019-2029
  • 銀屑病藥物市場（按分子類型）：2019-2029
  • 按給藥途徑劃分的銀屑病藥物市場：2019-2029
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章銀屑病藥物的全球市場定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第三章全球銀屑病藥物市場動態

• 銀屑病藥物市場影響分析（2019-2029）
  • 市場驅動力
    • 銀屑病的發病率增加。
    • 提高了對各種可用治療方案的認識。
    • 主要市場參與者的戰略舉措。
  • 市場挑戰
    • 銀屑病治療相關的高昂治療費用
    • 與藥物治療相關的健康風險
  • 市場機會
    • 新興國家/地區醫療保健基礎設施的擴展
    • 在製藥領域開展研發活動

第四章銀屑病藥物全球市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 投資招聘模式
• 分析師的結論和建議
• 頂級投資機會
• 關鍵成功策略

第 5 章風險評估 COVID-19 影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球銀屑病藥物市場：按藥物類別分類

• 市場概況
• 全球銀屑病藥物市場：按藥物類別、性能-潛力分析
• 2019-2029 年全球銀屑病藥物市場、按藥物類別估計和預測
• 銀屑病治療藥物市場細分分析
  • 腫瘤壞死因子抑製劑
  • PDE4抑製劑
  • 白細胞介素阻滯劑
  • 其他

第 7 章全球銀屑病藥物市場：按分子類型

• 市場概況
• 銀屑病藥物的全球市場：按分子類型進行性能潛力分析
• 全球銀屑病藥物市場、分子類型估計和預測 (2019-2029)
• 銀屑病治療藥物市場細分分析
  • 生物製品
  • 低分子化合物

第 8 章全球銀屑病藥物市場：按給藥途徑

• 市場概況
• 全球銀屑病藥物市場：按給藥途徑進行的性能-潛力分析
• 全球銀屑病藥物市場、按給藥途徑估計和預測（2019-2029 年）
• 銀屑病治療藥物市場細分分析
  • 口服劑
  • 父母代理人
  • 局部管理

第 9 章銀屑病藥物的全球市場：區域分析

• 銀屑病藥物市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年按藥物類別的估計和預測
    • 按分子類型估計和預測，2019-2029
    • 按給藥途徑估算和預測，2019-2029 年
  • 加拿大
• 歐洲銀屑病藥物市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太地區銀屑病藥物市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲銀屑病藥物市場概況
  • 巴西
  • 墨西哥
• 世界其他地方

第 10 章衝突信息

• 頂級市場策略
• 公司簡介
  • Astellas Pharma Inc.
    • 主要信息
    • 概覽
    • 財務（如果有數據）
    • 產品概覽
    • 近期發展狀況
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hofffmann-La Roche
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Eli Lilly and Company
  • G and W Laboratories Inc.

第 11 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Psoriasis Therapeutics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psoriasis is a type of skin disorders which causes skins cells to replace more quickly than normal. Psoriasis is associated with immune system and most commonly occurs on knees, elbows, trunk, and scalp. The increasing incidences of Psoriasis disease and rising awareness towards different treatment options available as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to National Psoriasis Foundation, USA - as of 2020, around 8 million individuals in the United States are affected by Psoriasis. In addition, around 125 million people worldwide suffers from Psoriasis, witnessing for over 2 to 3 percent of the global population. Moreover, as per World Health Organization (WHO) estimates - approximately 100 million individuals worldwide are affected by Psoriasis. Also, rising healthcare infrastructure in emerging economies and increasing R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, high treatment cost associated with Psoriasis treatment and health risks associated with medications impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psoriasis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the; leading region in terms of market share owing to presence of leading market players as well as increasing prevalence of Psoriasis in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pharmaceuticals sector as well as increasing incidences of skin disorders in the region.

Major market players included in this report are:

Astellas Pharma Inc.

AstraZeneca plc

Boehringer Ingelheim GmbH

F. Hofffmann-La Roche

GlaxoSmithKline plc

Merck and Co., Inc.

Valeant Pharmaceuticals International, Inc.

Biocon Limited

Eli Lilly and Company

G and W Laboratories Inc.

Recent Developments in the Market:

• In October 2021, India based Sun Pharmaceuticals Ltd. unveiled its medicine named ILUMYA for the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
• In December 2021, The Food and Drug Administration of USA has approved the expanded use of Amgen Inc's drug Otezla for the treatment of adults with mild to moderate plaque psoriasis. With this approval Otezla would be the first and only oral treatment option available for plaque psoriasis in adults.

Global Psoriasis Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Drug Class, Molecule Type, Route of Administration, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

TNF Inhibitors

PDE4 Inhibitors

Interleukin Blockers

Others

By Molecule Type

Biologics

Small Molecules

By Route of Administration

Oral

Parenteral

Topical

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Psoriasis Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Psoriasis Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Psoriasis Therapeutics Market, by Molecule Type, 2019-2029 (USD Billion)
  • 1.2.4. Psoriasis Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Psoriasis Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Psoriasis Therapeutics Market Dynamics

• 3.1. Psoriasis Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of Psoriasis disease.
    • 3.1.1.2. Rising awareness towards different treatment options available.
    • 3.1.1.3. Strategic initiatives from leading market players.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High treatment cost associated with Psoriasis treatment.
    • 3.1.2.2. Health risks associated with medications.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising healthcare infrastructure in emerging economies.
    • 3.1.3.2. Increasing R&D activities in pharmaceuticals sector.

Chapter 4. Global Psoriasis Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psoriasis Therapeutics Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Psoriasis Therapeutics Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 6.4.1. TNF Inhibitors
  • 6.4.2. PDE4 Inhibitors
  • 6.4.3. Interleukin Blockers
  • 6.4.4. Others

Chapter 7. Global Psoriasis Therapeutics Market, by Molecule Type

• 7.1. Market Snapshot
• 7.2. Global Psoriasis Therapeutics Market by Molecule Type, Performance - Potential Analysis
• 7.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Molecule Type 2019-2029 (USD Billion)
• 7.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Biologics
  • 7.4.2. Small Molecules

Chapter 8. Global Psoriasis Therapeutics Market, by Route of Administration

• 8.1. Market Snapshot
• 8.2. Global Psoriasis Therapeutics Market by Route of Administration, Performance - Potential Analysis
• 8.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
• 8.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Oral
  • 8.4.2. Parenteral
  • 8.4.3. Topical

Chapter 9. Global Psoriasis Therapeutics Market, Regional Analysis

• 9.1. Psoriasis Therapeutics Market, Regional Market Snapshot
• 9.2. North America Psoriasis Therapeutics Market
  • 9.2.1. U.S. Psoriasis Therapeutics Market
    • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Molecule Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Psoriasis Therapeutics Market
• 9.3. Europe Psoriasis Therapeutics Market Snapshot
  • 9.3.1. U.K. Psoriasis Therapeutics Market
  • 9.3.2. Germany Psoriasis Therapeutics Market
  • 9.3.3. France Psoriasis Therapeutics Market
  • 9.3.4. Spain Psoriasis Therapeutics Market
  • 9.3.5. Italy Psoriasis Therapeutics Market
  • 9.3.6. Rest of Europe Psoriasis Therapeutics Market
• 9.4. Asia-Pacific Psoriasis Therapeutics Market Snapshot
  • 9.4.1. China Psoriasis Therapeutics Market
  • 9.4.2. India Psoriasis Therapeutics Market
  • 9.4.3. Japan Psoriasis Therapeutics Market
  • 9.4.4. Australia Psoriasis Therapeutics Market
  • 9.4.5. South Korea Psoriasis Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Psoriasis Therapeutics Market
• 9.5. Latin America Psoriasis Therapeutics Market Snapshot
  • 9.5.1. Brazil Psoriasis Therapeutics Market
  • 9.5.2. Mexico Psoriasis Therapeutics Market
• 9.6. Rest of The World Psoriasis Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Astellas Pharma Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. AstraZeneca plc
  • 10.2.3. Boehringer Ingelheim GmbH
  • 10.2.4. F. Hofffmann-La Roche
  • 10.2.5. GlaxoSmithKline plc
  • 10.2.6. Merck and Co., Inc.
  • 10.2.7. Valeant Pharmaceuticals International, Inc.
  • 10.2.8. Biocon Limited
  • 10.2.9. Eli Lilly and Company
  • 10.2.10. G and W Laboratories Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Psoriasis Therapeutics Market, report scope
• TABLE 2. Global Psoriasis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Psoriasis Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Psoriasis Therapeutics Market estimates & forecasts by Molecule Type 2019-2029 (USD Billion)
• TABLE 5. Global Psoriasis Therapeutics Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
• TABLE 6. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Psoriasis Therapeutics Market
• TABLE 71. List of primary sources, used in the study of global Psoriasis Therapeutics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Psoriasis Therapeutics Market, research methodology
• FIG 2. Global Psoriasis Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Psoriasis Therapeutics Market, key trends 2021
• FIG 5. Global Psoriasis Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Psoriasis Therapeutics Market, porters 5 force model
• FIG 7. Global Psoriasis Therapeutics Market, pest analysis
• FIG 8. Global Psoriasis Therapeutics Market, value chain analysis
• FIG 9. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Psoriasis Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Psoriasis Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable